Novel genes relating to pain and use of the genes for pharmaceuticals
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 29, 2004
app pub date -
May 9, 2003
filing date -
May 10, 2002
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
An object of the present invention is to find novel genes that relate to, but are not limited to, pain, such as neuropathic pain, shingles pain, and post-herpetic neuralgia, and are induced upon pain, and provide a reagent, method and pharmaceutical for diagnosing and assessing pain, or preventing and treating pain. The present invention provides polynucleotides having nucleotide sequences composing novel genes, polypeptides encoded by the polynucleotides, and partial peptides thereof, recombinant vectors containing the polynucleotides, transformants having the recombinant vectors, antibodies against the polypeptides or partial peptides thereof, and the like, which are utilizable in biology, medicine, veterinary medicine, and the like. Further, the present invention provides a method for producing the polypeptides, compounds whose target molecules are the polynucleotides or the polypeptides, and pharmaceuticals containing the polypeptides or the partial peptides thereof, compounds whose target molecules are the polynucleotides or the polypeptides, or antibodies against the polypeptides. They are used particularly to diagnose and assess pain, or prevent and treat pain. Further, the present invention provides a method for identifying compounds and the like using these polynucleotides, polypeptides, or the partial peptides thereof, or salts thereof as a target molecule to prevent and treat pain, a method for using the identified compound to prevent and treat pain, a method for diagnostic monitoring a patient to be subjected to clinical evaluation for pain treatment, a method for monitoring the clinical efficiency of the compound, and a method for identifying a patient having diathesis of pain.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
TORAY INDUSTRIES INC | 1-1 NIHONBASHI-MUROMACHI 2-CHOME CHUO-KU TOKYO 1038666 ?1038666 | |
RIKEN | 2-1 HIROSAWA WAKO-SHI SAITAMA 3510198 ?3510198 | |
KABUSHIKI KAISHA DNA FORM | 3-35 MITA 1-CHOME MINATO-KU TOKYO 108-0073 |
International Classification(s)
- A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
- C07H:SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTI....
- C12Q:MEASURING OR TESTING PROCESSES INVOLVING ENZYMES O....
- C12P:FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESI....
- C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF
- C07K:PEPTIDES

- [Classification Symbol]
- [Patents Count]
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Hayashizaki, Yoshihide | Ibaraki, JP | 88 | 1273 |
Hirokawa, Hiroe | Kanagawa, JP | 4 | 2 |
Kamiya, Mamoru | Tokyo, JP | 7 | 67 |
Nakao, Kaoru | Kanagawa, JP | 6 | 12 |
Suzuki, Tomohiko | Kanagawa, JP | 30 | 220 |
Tanaka, Toshiaki | Kanagawa, JP | 351 | 6602 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events

Matter Detail

Renewals Detail

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
PAIR load has been initiated
A preliminary load of cached data will be loaded soon. Current PAIR data will be loaded within twenty four hours.
File History PDF
Thank you for your purchase! The File Wrapper for Patent Number 20040019006 will be available within the next 24 hours.
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:

Last Refreshed On:
Changes done successfully
Important Notes on Latency of Status data
Please note there is up to 60 days of latency in this Status indicator for certain status conditions. You can obtain up-to-date Status indicator readings by ordering PAIR for the file.
An application with the status "Published" (which means it is pending) may be recently abandoned, but not yet updated to reflect its abandoned status. However, an application filed less than one year ago is unlikely to be abandoned.
A patent with the status "Granted" may be recently expired, but not yet updated to reflect its expired status. However, it is highly unlikely a patent less than 3.5 years old would be expired.
An application with the status "Abandoned" is almost always current, but there is a small chance it was recently revived and the status not yet updated.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.